Delivery Order SPE2DB24D9803-SPE2DB25FJSNU
Award Date 9/10/25
Potential Completion Date 9/11/25
Potential Value $3.3K
Federal Agency
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $7,410.00 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of TYPHIM VI 25 MCG/0.5 ML syringes. The award, issued on July 28, 2025, with an ultimate completion date of July 29, 2025, carries no set-aside designation. This delivery order falls under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with DLA under the...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a $7,410 firm fixed-price delivery order by the Defense Logistics Agency on August 4, 2025, with an ultimate completion date of August 5, 2025. The contract calls for the delivery of TYPHIM VI 25 MCG/0.5 ML syringes—a typhoid conjugate vaccine used for immunization purposes—to support Department of Defense healthcare requirements. This delivery order was issued without...
- The Defense Logistics Agency awarded a $4,139.40 firm fixed-price delivery order to DMS Pharmaceutical Group Inc. for TYPHIM VI 25 MCG/0.5 ML syringes on September 8, 2025, with completion targeted for September 9, 2025. This delivery order was issued under DMS Pharmaceutical Group's existing single-award Indefinite Delivery Contract with DLA valued at $499,999,999 and valid through November 2026. The contract carries no set-aside designation, allowing DMS Pharmaceutical Group to compete...
- The U.S. Defense Logistics Agency, through its Medical Supply Chain office, awarded a firm fixed-price delivery order valued at $1,854.46 to DMS Pharmaceutical Group Inc. for Typhoid VI Polysaccharide vaccine. The delivery order was issued on September 9, 2025, with an ultimate completion date of September 19, 2025, and will be fulfilled at the contractor's facility in Park Ridge, Illinois. This award utilizes no set-aside designation and represents a single delivery under DMS Pharmaceutical...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $22.23K by the Defense Logistics Agency on August 12, 2025, for the supply of TYPHIM VI 25 MCG/0.5 ML syringes. This firm fixed-price delivery order, with an ultimate completion date of August 13, 2025, represents a single shipment under the company's larger Indefinite Delivery Contract with DLA valued at $499.99M and valid through November...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $14,079 contract is for the delivery of TYPHIM VI 25 MCG/0.5 ML SYRNG 0.5ML, a vaccine product, with a completion date of July 18, 2025. DMS Pharmaceutical Group has a significant Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, valued at $499,999,999...
- The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $3,705.00 to DMS Pharmaceutical Group Inc. for TYPHIM VI 25 MCG/0.5 ML syringes on July 28, 2025, with an ultimate completion date of July 29, 2025. TYPHIM VI is a typhoid vaccine indicated for immunization against typhoid fever, making this delivery order a critical component of the Department of Defense's medical supply chain. The contract carries no set-aside designation, and performance is scheduled at DMS...
- The U.S. Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business, to provide 4,564,220,848 units of the TYPHIM VI 25 MCG/0.5 ML SYRNG 0.5ML vaccine. The $1,748.69 delivery order was issued under DMS Pharmaceutical's $4,999,999 indefinite delivery vehicle (IDV) contract SPE2DB with DLA to supply a broad range of pharmaceutical items to U.S. military medical facilities worldwide. This contract award does not...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, has been awarded a firm fixed-price delivery order valued at $1,482.00 for Typhoid VI Polysaccharide vaccine. The contract, issued by the Defense Logistics Agency's Medical Supply Chain on August 18, 2025, with an ultimate completion date of August 28, 2025, carries no set-aside designation. This delivery order is issued under DMS Pharmaceutical Group's larger single-award...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,781.69 to DMS Pharmaceutical Group Inc. for the supply of Typhoid VI Polysaccharide vaccine. This firm fixed-price delivery order, issued on September 8, 2025, represents a single transaction under DMS Pharmaceutical Group's larger Indefinite Delivery Contract (IDC) with the DLA valued at approximately $500 million and extending through November 2026. The delivery order specifies Park Ridge, Illinois as the place of...